Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-18-063795

Chief Legal Officer gave up 306 shares (to pay taxes)

  • Chief Legal Officer acquired 1,075 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Ali-Jackson Kamil Chief Legal Officer 2018-12-18 Option exercise +1,075 79,951 D
Ali-Jackson Kamil Chief Legal Officer 2018-12-18 Shares withheld for taxes −306 $6.30 $1,928 79,645 D
Derivatives
Ali-Jackson Kamil Chief Legal Officer 2018-12-18 Option exercise · Restricted Stock Units −1,075 1,075 D
Loading xslF345X03/doc4.xml…